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Abstract 
Ternary complexes of histidine amino acid (Schiff base) were synthesized, characterized and tested against multi-
drug resistant pathogens. The metal ion centers included Cu (II), Ni (II) and Co (II). These complexes were 
characterized using physico-chemical and spectroscopic analytical methods. All the complexes are found to be 
considerably soluble in both polar and non-polar solvents including methanol, ethanol, butanol, acetone, ethyl 
acetate, and benzene and di ethyl-ether. Electronic Absorption Studies using FT-IR spectrophotometer revealed ν 
(O-H), ν (C=O), ν (C=N), ν (M -N) and ν (M-O) occurred between 3410 - 3417, 1751 - 1753, 1519 – 1521, 671 – 
678, 439 – 470 cm-1 respectively in complexes and ligand. UV-Visible was further used to elucidate the complexes 
resulting in transitions characteristics of the ligand and complexes. The Schiff base showed no antimicrobial 
activity at various therapeutic concentrations. However, the metal complexes exhibited broad spectrum antibiotic 
activities against the multi-drug resistant pathogens at minimum inhibitory concentration (MIC ≤ 200 µg/ml). The 
metal complexes showed strong activity against the isolates at medium and high concentrations, the bacteria strains 
included E.coli, P. aeruginosa, S. typhi and S. aureus and the fungi strains of Candida albicans, Aspergillus flavus 
and Aspergillus niger. The bioactivity recorded against these multi drug resistant pathogens indicates the potentials 
of these complexes for further therapeutic studies. 
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INTRODUCTION 
Antimicrobial resistance to therapeutic drugs is fast becoming a global concern with rapid increase of resistant 
bacteria. Established treatable conditions are now becoming untreatable, examples are methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). [1] M. tuberculosis (Strain no: 
H37Rv ATCC 27294) is also showing drug resistance to isoniazid, rifampicin, ethambutol. 
The multi-drug resistant list also extends to gram negative organisms like Escherichia coli, Shigellaflexeneri, 
Pseudomonas aeruginosa and Salmonella typhi and also Gram-positive Bacillus subtilis bacterial strains. Candida 
albicans, Aspergillus flavus, Fusarium solani, and Candida glaberata are some fungal pathogens are also showing 
the resistance feature against established drugs. [2] 
This new trend of infectious diseases still remains an important and challenging one because of a combination 
of factors including new discoveries of infectious diseases and the increasing number of multi-drug resistant 
microbes. There is a pressing necessity for the finding of novel compounds and complexes with better 
antimicrobial activities, preferably acting through a diverse exploit mechanism. The action mechanism should be 
different from the current classes of antimicrobial agents and drugs to which many clinically active microbial 
agents are now resistant. Given the disturbing upsurge in infectious maladies instigated by diverse pathogens and 
the expansion of multi-drug resistance, investigators are examining new different antibacterial representatives. 
Consequently, fresh anti-pathogenic representatives with distinct action mechanisms and nano-technological 
properties have to be synthesized for the treatment of multi-drug resistant bacterial diseases. 
This study aims to synthesize, characterize and carry out antimicrobial activities of Cu (II), Co (II) and Ni (II) 
metals complexes with Amino acid (histidine) ligand. This project is limited to the elementary processes of 
organometallic based drug design and evaluation. This procedure includes the synthesis of the proposed complexes, 
their physico-chemical and instrumental characterization and testing the antimicrobial effectiveness of these 
complexes.    
 
Materials and methods 
Analytical grade reagents were purchased from sigma-Aldrich chemicals. All reagents were used directly without 
further modifications. All glass wares were properly washed with dilute nitric and distilled water and oven dried. 
The solubility of the metal complexes was tested using various polar solvents including water, methanol, ethanol, 
butanol, acetone, ethyl acetate and non-polar solvents like benzene and diethyl ether. Melting points of both the 
Schiff base ligand and it corresponding complexes was determined by an electrical melting point determination 
apparatus. Electronic Absorption Studies indicated the UV-Visible spectra in the   region 200-1100 nm were 
measured by systronics double beam spectrophotometer 2202 model using calibrated quartz cells. The metal 
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complexes were subjected to IR spectral analysis to determine   molecular interaction and functional group, 
structural elucidation and bond vibration of each of the complexes. The in vitro anti-microbial screening was 
performed. Nutrient agar and Sabouraud Glucose agar were used as culture media. The multi-drug resistant 
pathogens used include Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi and 
Gram-positive Staphylococcus aureus and the fungi samples include Candida albicans, Aspergillus flavus, and 
Aspergillus niger for testing antibacterial activity, and was collected from the Baurau Dikko Hospital clinical 
laboratory, Kaduna. 
 
Preparation of the Schiff base (Ligand) 
All the required chemicals were used as bought without further modification. 20 mmol of amino acid histidine was 
added into 30 ml of water and solution stirred, 20 mmol acetylacetone was also added to 10 ml of ethanol, and 
mixed well. Both solutions were then mixed together.  The mixture was refluxed for 6 hours at 50oC. During 
refluxing the color of the solution spun to yellow at first and later spun to orange. [2] 
 
Recovery of the Ligand 
Upon the completion of the reaction, the reaction mixture was transferred to a beaker and cooled on an ice bath to 
afford a solid product. After cooling the mixture, solid product was settled at the bottom of the beaker. The solid 
product was recovered by the following steps, evaporation of excess solution from the mixture by heating the 
solution on a hot plate and after heating the solution mixture was kept in an ice bath for a few minutes to make it 
cool and finally   solid residue was filtered with a filter paper. [3] 
 
Preparation of metal complexes 
Exactly 500 mg of histidine ligand was added into 20 mL hot methanol and    mixed well. At the same time, 500 
mg of the metal chlorides were taken and mixed with 20 mL of ethanol with a magnetic stirrer. Then both solutions 
were mixed and refluxed for 4 hours in a refluxing unit at a temperature of 450C. After the completion of the 
reaction, the solution mixture was transferred into a beaker and then cooled om an ice bath. Once the solution was 
cooled the solid product (metal comp lex) was settled down at the bottom of the beaker and filtered. [4] 
 
Recovery of metal complex 
The solid product was obtained by filtering with filter paper. The obtained solid product was washed with ethanol 
twice, washed with ether and finally washed again with ethanol. The filtrate product was air dried to afford the 
desired product and the product was handled very carefully as the product may be hygroscopic in nature, long 
exposure to air can damage. [5] 
 
Antibacterial and Antifungal bioassay 
Antibacterial assay 
Muller Hilton Agar was prepared and sterilized according to manufacturer standard. 20 mL of media was poured 
into the Petri plates and allowed for solidify. The bacterial lawn culture was made using sterile cotton swab and 
labelled. A metallic borer was used to make wells in the media with a center of 24 mm. the suggested concentration 
50 μL of the test sample 100 mg/mL in water was poured in the respective wells. These plates were then incubated 
immediately at 37◦C for 24 hours to facilitate healthy condition of bacterial growth. The antibacterial activity was 
determined by measuring the diameter of zones showing total inhibition in millimeters (mm). Growth inhibition 
was compared with the DMSO. [6] 
 
Antifungal assay 
The antifungal activities of these metal complexes were studied against three fungal strains, Candida albicans, 
Aspergillus flavus and Aspergillus niger. Sabouraud dextrose agar was prepared according to manufacturer’s 
instructions and sterilized in an autoclave. The culture plates were pour-plated just like Muller Hilton Agar case. 
Upon the solidification of the media, respective fungal spore were swab on it. A sterile metallic borer was used to 
make wells in the media with centers of 24 mm. The commended concentration of the test sample, 100 mg/mL in 
water was introduced in these wells. The plates were incubated at 300oC for 72 hours. The outcomes were 
chronicled as zones of inhibition in millimeter (mm). [7] 
 
Minimum inhibitory concentration 
The minimum inhibitory concentration of the complexes was determined using the tube dilution method. The 
following concentrations 300, 200 and 100 in μg/mL of the metal complexes solution were prepared. Cleaned test 
tubes were used; the different concentration of metal complexes was made, the volume of medium made up to 20 
mL with nutrient broth after which the control was prepared with 2 mL of nutrient broth without any metal complex 
and sterilized the medium at 121oC temperature at 15 lbs pressure for 15 minutes in autoclave. At the end of the 
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sterilization, the medium was allowed to cool and 0.2 mL of overnight cultures of each organism was dispensed 
into sterile medium and incubated for 24 hours and the activity measured. [7] 
 
RESULTS 
Table 1, shows the physical properties of the ligand and complexes 
Compounds Colour Melting Point Yield (%)  
[NiHis2(H2O)2] Green 166oC 62.75  
[CuHis2(H2O)2] Green 160oC 70.45  
[CoHis2(H2O)2] Pink 163oC 68.35  
Schiff base Yellow 244oC 66.20  
 
Table 2, shows the Infrared Frequencies (in cm-1) of the ligand and Metal Complexes. 
S/N Compounds ν(O-H) ν (C=O) ν (C=N) ν (M -N) ν(M-O) 
1. [NiHis2(H2O)2] 3410 1751 1519 678 447 
2. [CuHis2(H2O)2] 3410 1751 1519 671 439 
3. [CoHis2(H2O)2] 3417 1753 1521 671 470 
4. Schiff base - 1751 1519 - - 
 
Table 3, The antibacterial activity of the Schiff base ligand and its metal complexes in millimeters (mm) are shown 
below. 
S/N Name of Bacteria Pathogens Zones of inhibition of ligand and metal complexes in 
millimeter (mm) 
Histidine      Cu              Ni                Co      DMSO 
1. 
2.  
3. 
4. 
Escherichiacoli 
Pseudomonas aeruginosa 
Salmonella typhi 
Staphylococcus aureus 
00                   25             22               23         00 
00                   23             18               23         00 
00                   20             24               24         00 
00                   27             25               29         00 
 
Table 4; Minimum Inhibitory Concentration of the metal complexes against bacterial pathogens   
S/N Bacteria Compounds Zones of inhibition of ligand and metal complexes. 
 300μg                     200μg                  100μg 
1. 
 
 
2. 
 
 
3. 
 
 
4. 
 
E.coli 
 
 
P. aeruginosa 
 
 
S. typhi 
 
 
S. aureus 
[NiL2(H2O)2] 
[CuL2(H2O)2] 
[CoL2(H2O)2] 
[NiL2(H2O)2] 
[CuL2(H2O)2] 
[CoL2(H2O)2] 
[NiL2(H2O)2] 
[CuL2(H2O)2] 
[CoL2(H2O)2] 
[NiL2(H2O)2] 
[CuL2(H2O)2] 
[CoL2(H2O)2] 
    +                             +                        - 
    +                             +                        - 
    +                             +                        - 
   +                             +                         - 
   +                             +                         - 
   +                             +                         - 
   +                             +                         - 
   +                             +                         - 
   +                             +                         - 
   +                             +                         - 
   +                             +                         - 
   +                             +                         - 
    
                                                              
Table-5; Antifungal activity of the Schiff base ligand and its metal complexes in millimeters (mm) 
S/N Name of Fungi Pathogens Zones of inhibition of ligand and metal complexes in 
millimeter (mm) 
Histidine        Cu        Ni           Co      DMSO 
1. 
2. 
3. 
Candida albicans 
Aspergillus flavus 
Aspergillus niger 
00                   24          26            28        00 
00                   18          27            26       00 
00                   22          26            27       00 
 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) DOI: 10.7176/JNSR 
Vol.9, No.10, 2019 
 
12 
Table-6; Minimum Inhibitory Concentration of metal complexes against fungi pathogens 
S/N Fungi Compound Zones of inhibition of ligand and metal 
complexes. 
300μg                200μg              100μg 
1. 
 
 
 
2. 
 
 
 
3. 
Candida albicans 
 
 
 
Aspergillus flavus 
 
 
 
Aspergillus niger 
[NiHis2(H2O)2] 
[CuHis2(H2O)2] 
[CoHis2(H2O)2] 
 
[NiHis2(H2O)2] 
[CuHis2(H2O)2] 
[CoHis2(H2O)2] 
 
[NiHis2(H2O)2] 
[CuHis2(H2O)2] 
[CoHis2(H2O)2] 
+                         +                      - 
+                         +                      - 
+                         +                      - 
 
+                         +                      - 
+                         +                      - 
+                         +                      - 
 
+                         +                      - 
+                         +                      -  
+                         +                      - 
 
DISCUSSION 
The schiff base ligand was prepared by refluxing calculated amounts of amino acid histidine with acetylacetone in 
ethanol and water. The metal complexes was prepared by using hydrated metal chloride salts with the amino acid 
histidine (Schiff base) in appropriate molar ratios of metal-ligand as illustrated. [3] The Schiff base which is yellow 
in colour had a melting point of 244oC and percentage yield of 66.20%. The complexes of nickel (II), copper (II) 
and Cobalt (II) synthesized are blue, green and pink in colour and have decomposition temperatures of 166oC, 
160oC and 163oC, and percentage yield of 62.75, 70.45 and 68.35% respectively as shown in Table 1. The metal 
complexes were found to be soluble in all the polar solvents dissolved in including water, methanol, ethanol, 
butanol, acetone, ethyl acetate and in the non-polar solvents of benzene and di ethyl-ether. The diverse coordination 
geometry of transition metals opens an exciting window for the discovery of novel and potent metallodrugs with 
novel mechanisms of action. [8] 
Moreover, Electronic Absorption Studies indicated the UV-Visible spectra in the   region 200-1100 nm were 
measured by systronics double beam spectrophotometer 2202 model using calibrated quartz cells. The 
measurements were carried out at room temperature. The electronic absorption spectrum of the Schiff base ligand 
indicated two absorption bands around 340 nm and 420 nm correspondingly. The first band around 340 nm 
corresponded to ∏→∏* of the azomethine group and the second band at 420 nm corresponded to ∏→∏* 
transitions. The distinctive electronic absorption spectrum of the Co (II) complexes. The electronic spectra of Co(II) 
complexes display absorption bands in the region of 8000-10000 cm-1 and 18000-20000 cm-1 consequent to the 
transitions 4T1g (F) → 4T2g(F) (ν1) and 4T1g (F) → 4T1g (P) (ν3) respectively (Underhill and Billing1966). In the 
current work Co (II) complexes shows the absorption bands in the region 240 nm and 384 nm corresponding to ν1 
and ν3 transitions respectively. The ν2 band is not observed due to strong proximity to ν3 transition. These bands 
are distinguishing of high spin octahedral Co (II) complexes. [2] Upon complexation, the further reduced polarity 
of Co (II) ion was due to ligand orbital overlap and partial positive charge sharing of the Co (II) ion with donating 
lone pair groups. Furthermore, the delocalization of π-electrons upsurges over the whole ring and expands the 
lipophilicity of the whole complexes. The amplified lipophilicity enhances the chances of the infiltration of the 
compounds into lipid membranes and obstructing spots of the metal binding in the enzymes of pathogens. These 
organometallic compounds also alter the respiration route of the pathogenic cells and thus stopping the protein 
synthesis consequently limiting additional development of these organisms.[9] 
The Ni(II) complex indicated three bands at 246, 261 and 266 nm ascribed to the  3A2g →3T2g (ν1), 3A2g →3T1g 
(F) (ν2) and 3A2g→3T1g (P) (ν3) transitions in that order, which is an indication of the octahedral geometry around 
Ni(II) ion center. This also holds true for the Cu(II) complex result similar to other reported complexes. [12] The 
electronic spectra of Cu(II) complexes displayed two important bands, first a low-intensity band at about 16,243 
cm-1 which is due to 2Eg → 2T2g transition and another high-intensity band at 26,366 cm−1 is assigned to ligand-
metal charge transfer. A distorted octahedral geometry is suggested around the Cu(II) ion  on the basis of electronic 
spectra. [10] Upon complexation, the further reduced polarity of Cu (II) ion was due to ligand orbital overlap and 
partial positive charge sharing of the Cu (II) ion with donating lone pair groups. Furthermore, the delocalization 
of π-electrons upsurges over the whole ring and expands the lipophilicity of the whole complexes. 
The infrared spectra of the amino acid histidine Schiff base showed a band at 1632 cm-1 indicative of v(C=N) 
stretching frequencies. Similar bands are observable in the spectra of the corresponding metal complexes, but in 
lower frequencies, indicating that the Schiff base has coordinated to the respective metal ions. The coordination 
positions of the histidine amino acid in the M(II) complexes are confirmed by observing the well-built bands in 
the far IR spectra region. The bands in the spectra of the metal (II) complexes in the ranges of 460 – 480 and 630 
- 625 cm-1 progressively are assigned to the vibrational modes of v(M-N) and v(M-O) confirming the complexation 
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of the Schiff base to the individual metal ions as in the Table 2. The tough bands at 2922 and 2900 cm-1 are 
indicative of the v(O-H) stretching frequencies for coordinated water in M (II) Schiff base complexes. [11] 
The dissociation constant of the amino histidine Schiff base as reported [1] is 8.81, demonstrating that it is a 
weak acid. The empirical formula of the metal (II) ions, water content and the Schiff base from their known 
percentage compositions in the complexes, suggested the general formula [MHis2(H2O)2]. 
The antibacterial activity evaluation of the Schiff base and the metal (II) complexes have been determined in 
comparism with the standard Dimethyl sulfoxide (DMSO). Organometallic drugs consist of basically two parts: 
the drug itself, usually a hydsroxamic acid, and an ancillary ligand. The mechanism of action involves dissociation 
of the complex inside the bacteria target promoting the release of the drug to its target. [12] The diameter of 
inhibition zone in (mm) was measured for each treatment. The organisms were found to be resistant to the Schiff 
base at all concentrations. However, the metal (II) complexes showed strong activity against the isolates at medium 
and high concentrations as shown in Tables 3 and 4.  
 
CONCLUSION 
In view of these results of the bioactivities of these complexes synthesized, it has shown that histidine complexes 
have the potentials against multi drug resistant pathogens. Nevertheless, further studies on the mechanism of 
growth inhibition, toxicity and invitro analysis are needed, in order to evaluate their potential of therapeutic 
applications. The novel approach of organometallic complexes in their biological activity against these multi drug 
resistant pathogens gives more rooms for further experimentations and analysis especially when the complexes 
mimics naturally occurring complexes in the living system.  
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